Consider investing in boutique investment bank PJT Partners (PJT), which is benefiting from the current boom in mergers and acquisitions and reported fantastic earnings. In the highly competitive obesity drug market, Eli Lilly (LLY) is emerging as the clear winner, making it a more attractive investment than competitor Novo Nordisk (NVO). Avoid restaurant stocks like Cava (CAVA) and Papa John's (PZZA), as they are showing significant weakness due to lower-income consumers cutting back on spending. Be selective with AI hardware plays, avoiding companies with non-proprietary products like server-maker Supermicro (SMCI), which recently reported a poor quarter. Finally, steer clear of FICO (FICO), as the company is entering a risky price war that could threaten its long-term profitability.

U.S. Economy & Market Overview

• The speaker, Steve Eisman, describes the current environment as a "K-shaped economy".
  • The top is driven by AI and AI-related companies.
  • Many other parts of the U.S. economy are struggling.
• There is increasing evidence of a cooling labor market, with private data showing the most job cuts for any October in over 20 years.
• Consumer spending is being driven by the top 10% of households. Lower and middle-income consumers are pulling back, making the economy more prone to a downturn if the stock market corrects.
• The market is top-heavy. The S&P 500 (market-cap weighted) is up 16.5% for the year, while the S&P 500 Equal Weight Index (SPW) is only up 6.9%.
  • This large gap (~1000 basis points) shows that a few large-cap tech stocks are driving the majority of the market's gains.
  • The top 10 companies make up an astonishing 42% of the S&P 500 index.
  • This trend has been consistent for three years. The speaker suggests we should "really start to worry" if this performance gap gets worse.

Takeaways

• Investors should be aware that the overall market's strength is concentrated in a small number of very large technology companies.
• A slowdown in the AI sector could have an outsized negative impact on major indices like the S&P 500 and Nasdaq.
• Be cautious about companies that rely on lower and middle-income consumers, as they are showing signs of financial stress.

Palantir (PLTR)

• The company reported great numbers, beating expectations for both earnings and revenue.
  • Reported earnings of $0.21 vs. $0.17 expected.
  • Reported revenue of $1.18 billion vs. $1.09 billion expected.
• Guidance was strong and better than expected, but not by a huge margin.
• The stock was down over 7% the day after reporting, despite the strong results.
• The reason for the drop is its "nosebleed" valuation. The stock trades at over 200 times its 2026 P/E multiple. At this level, a company must "blow expectations out of the water," not just beat them.
• Hedge fund manager Michael Burry (of "The Big Short" fame) reportedly has a large short position on the stock.
• Eisman notes that the short thesis is purely based on valuation. He personally believes that shorting a great company with a great story just because of high valuation is "usually a recipe for disaster."

Takeaways

• Palantir is executing exceptionally well, but its stock price already reflects immense optimism.
• The stock is highly volatile and sensitive to any news that doesn't significantly exceed already high expectations.
• Investing in Palantir at these levels is a bet that its incredible growth story will continue for a long time, justifying the extreme valuation. Shorting it is a bet that the valuation is unsustainable.

Advanced Micro Devices (AMD)

• The chip company reported a "beat and raise" quarter.
  • Reported earnings of $1.20 (30% growth) vs. $1.16 expected.
  • Reported revenue of $9.3 billion (36% growth) vs. $8.7 billion expected.
• Despite the strong results, the stock was under pressure after the report.
• The issue was guidance: while revenue guidance was above consensus, the gross margin guidance of 54.5% was only equal to what analysts already expected. Some investors wanted more.

Takeaways

• Like Palantir, AMD is another example of an AI-related stock where simply meeting expectations is not enough to please the market.
• Investors are closely watching profit margins, not just revenue growth, as a key indicator of health in the competitive chip sector.

Supermicro (SMCI)

• A server manufacturer that competes with Dell, it has been a beneficiary of the AI boom.
• The company reported a bad quarter, missing estimates for sales and earnings and giving a disappointing forecast.
• The stock was down 9% on the news.
• Eisman's view is that Supermicro's problem is that its products (servers) are not proprietary. This leads to price wars and pressure on profit margins.

Takeaways

• This highlights the difference between various players in the AI space. Companies with unique, proprietary technology (like NVIDIA) have a much stronger business model than those selling commoditized hardware.
• Investors should differentiate between AI companies with a strong competitive advantage and those that are simply riding the wave with non-proprietary products.

PJT Partners (PJT)

• A boutique investment bank that benefits from the current boom in mergers and acquisitions (M&A).
• The company reported "fantastic numbers" that significantly beat expectations.
  • Revenue of $447 million vs. an estimate of $335 million.
  • Earnings per share of $1.85 vs. an estimate of $1.40.
• The speaker, Steve Eisman, discloses that he owns PJT.

Takeaways

• The M&A advisory sector is currently very strong.
• Boutique investment banks like PJT and Evercore (EVR) are a way to invest in this theme outside of the large-cap banks like Goldman Sachs (GS) or Morgan Stanley (MS).

Apollo Global Management (APO)

• An alternative asset manager involved in private equity and private lending.
• The company reported "excellent" numbers, beating expectations for revenue and earnings.
  • Fee-related earnings (a key metric for stability) jumped 23%.
  • Total assets under management reached $900 billion.
• The stock was up 7% on the news.
• Despite the good results, there is a general worry among investors about the massive growth in the private credit market and what might happen in a recession.

Takeaways

• Apollo is performing very well, but the entire private credit sector carries a risk that is not apparent today but could surface during an economic downturn.
• For now, the company is executing well and the market is rewarding it.

Restaurant Sector: Cava (CAVA) & Papa John's (PZZA)

• The transcript highlights weakness in restaurants that cater to lower and middle-income consumers.
• Cava (CAVA): The fast-casual chain cut its full-year forecast for the second straight quarter because "younger consumers visited less often." Eisman suggests this is a proxy for lower-income consumers pulling back.
• Papa John's (PZZA): The company missed on earnings and revenue. The stock was already down 20% this week alone on news that Apollo (APO) had withdrawn its offer to take the company private.

Takeaways

• The restaurant sector is showing clear signs of the "K-shaped" economy. Chains catering to budget-conscious consumers are struggling.
• This is a bearish sign for the health of the average American consumer and could be a leading indicator of a broader economic slowdown.

Healthcare: Novo Nordisk (NVO) vs. Eli Lilly (LLY)

• The "obesity drug wars" continue, with a clear winner emerging.
• Novo Nordisk (NVO): The maker of Wegovy and Ozempic trimmed its sales forecast for a fourth time this year due to disappointing sales. Its stock dropped more than 2%.
• Eli Lilly (LLY): The speaker states that Lilly is "clearly winning" the obesity drug war. Lilly's stock rose 1.5% on the back of Novo Nordisk's negative report.

Takeaways

• Eli Lilly (LLY) appears to have a stronger position and better momentum in the highly lucrative market for obesity drugs.
• Investors in this space should recognize that this is a competitive market, and one company's loss can be another's direct gain.

FICO (FICO)

• Fair Isaac Corp., the company behind the FICO credit score, has a virtual monopoly on determining consumer creditworthiness.
• The company's results were fine, but its guidance for future earnings was weak, coming in below analyst expectations.
• The main issue is a price war in credit scoring, which FICO itself seems to have initiated by creating a new, cheaper product.
• Eisman views this as "potentially dangerous" because FICO's main competitors are the credit bureaus (Experian, TransUnion, Equifax), who are also the suppliers of the data FICO needs to create its scores. These bureaus have their own competing product called Vantage Score.

Takeaways

• FICO's long-standing monopoly and pricing power may be under threat.
• Starting a price war with competitors who are also your essential suppliers is a very risky business strategy. This is an "evolving story" to watch closely as it could fundamentally change FICO's business model.